Navigation Links
Summit Doppler Announces the Seated ABI for the Diagnosis of Peripheral Arterial Disease
Date:7/8/2008

Patients with disabilities or mobility impairments can be tested for peripheral arterial disease (P.A.D.) in a comfortable seated position using

Summit Doppler's Vista AVS

GOLDEN, Colo., July 8 /PRNewswire/ -- Summit Doppler Systems, a leading manufacturer of ultrasound Doppler products, introduced today a significant upgrade to the Vista AVS, a full-featured arterial physiologic exam system. The new Vista AVS has advanced features, one of which allows clinicians to perform the ankle brachial index (ABI) exam for the diagnosis of peripheral arterial disease (P.A.D.) in the seated position, the patent-pending Seated ABI.

The ABI exam, which compares systolic blood pressures obtained at the ankles and arms, was traditionally performed with the patient in the supine position to prevent error from hydrostatic pressure. This position requirement made the exam difficult for patients with disabilities or mobility impairments. Recent studies have shown these patients have reduced access to many diagnostic exams. Fortunately, the new Vista AVS calculates ABI values for seated patients by compensating for the effects of gravity on the lower extremity pressures. Now for the first time, patients who are immobile or unable to lay supine can be seated for ABI measurement.

"Our vision is to significantly broaden the availability of the ABI exam without compromising accuracy," said Dave Jones, Vice President of Engineering for Summit Doppler. "With the Seated ABI, we are making the ABI exam readily available to millions of people who have mobility issues or medical conditions that prohibit testing in the supine position. The Seated ABI is the first of a series of steps we're making toward delivery of a faster and more affordable ABI exam."

Along with the ability to perform the Seated ABI using hydrostatic pressure correction, the new Vista AVS allows clinicians to customize segmental studies by selecting the number and location of arterial sites. While the ABI exam is performed as the initial test to diagnose P.A.D., segmental studies are performed on patients with P.A.D. to localize the occlusion in the lower limbs.

P.A.D. affects 8 to 12 million people in the U.S. every year. It is characterized by the narrowing of the arteries in the legs caused by plaque build-up, also known as atherosclerosis. Early detection can prevent further cardiovascular events, such as heart attack, stroke and death. Awareness of P.A.D. and its diagnosis and treatment are rapidly increasing. Better equipment and reimbursement for the diagnosis is making the exam cost effective for office-based medical practices.

The Vista AVS, first released in 2007, was designed by Summit Doppler to make the ABI and other arterial exams faster, easier, and more affordable. With its new features and significant cost advantage, the 2008 Vista AVS will broaden the availability of arterial diagnostic studies and help reduce overall healthcare costs.

Summit Doppler Systems, located in Golden, Colorado, manufactures ultrasound Doppler systems used to detect fetal heartbeat and monitor peripheral arterial blood flow. With continuous research and development, Summit Doppler is dedicated to providing new technologies to better serve the needs of healthcare providers, which ultimately provide improved healthcare for all of us.
http://www.summitdoppler.com


'/>"/>
SOURCE Summit Doppler Systems
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Cogdell Spencer Inc. Acquires Summit Professional Plaza I and II in Brunswick, Georgia
2. Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
3. Education Key Focus of Michigan Policy Summit
4. Skinvisible to Present at Merriman Curhan Ford & Co.s Investor Summit 2007
5. DURECT to Present at Merriman Curhan Fords Annual Investor Summit
6. Partners Rx Chief Pharmacy Officer, Richard Bullard on Panel Discussion at the Fall 2007 Managed Markets Summit (MMS) in Phoenix, AZ.
7. Hooper Holmes Launches Health & Wellness Division at 2007 Disease Management Leadership Forum and Integrated Care Summit
8. Historic Breast Cancer Global Advocate Summit Convenes in Budapest, Hungary on September 29-30
9. Summit on Spinal Muscular Atrophy
10. Global Leaders Converge for Special Olympics Global Policy Summit
11. Sanofi-aventis US Chairman Tim Rothwell Addresses CMSAs Collaborative Practice Summit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... , ... May 25, 2016 , ... Casa Velas, an ... properties of precious stones to complement its new wellness suites . The two ... and feature a plethora of special services and insuite amenities, from a custom soap ...
(Date:5/25/2016)... , ... May 25, 2016 , ... America Walks ... Carol Reichbaum, M.S.L., M.S.P.A., of the University of Pittsburgh Graduate School of Public ... will enable Ms. Reichbaum and 24 other advocates from around the country to participate ...
(Date:5/25/2016)... ... 2016 , ... "FCPX LUT Intense allows users to cycle through different high-contrast ... CEO of Pixel Film Studios. , With the FCPX LUT Intense Plugin ... to their footage. A LUT is a Lookup Table that contains a mathematical formula ...
(Date:5/25/2016)... ... May 25, 2016 , ... Consumer access to organic ... June 2016, Kashi®, a maker of whole grain cereals and other plant-based foods, will ... ingredient: hard red winter wheat processed by Hesco/Dakota Organic Products. , The transitional ...
(Date:5/25/2016)... New Jersey (PRWEB) , ... May 25, 2016 , ... ... specialized technology firm will be selling the device branded as Stern’s Real Time ... is geared to bedbugs to the hotel and motel industry, colleges for use in ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... 2016   , Study ... overall bowel cleansing and superiority in , ... of the ascending colon ... Norgine B.V. today announced new positive data from the ... bowel preparation) versus standard 2 litre PEG with ascorbate. The study ...
(Date:5/24/2016)... N.J. , May 24, 2016 ... oncology drug development company, today provided an update ... dose escalating clinical trial combining GEN-1, the Company,s ... the treatment of newly-diagnosed patients with advanced ovarian ... interval debulking surgery.  GEN-1 is an IL-12 DNA ...
(Date:5/24/2016)... , May 24, 2016 ... ™ , la première endoprothèse ... cathéters destinés à l,intervention portant sur les ...   OrbusNeich, entreprise mondiale spécialisée ... de changer la vie, a élargi son ...
Breaking Medicine Technology: